Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

gliclazide

A short-acting, relatively high-potency, second-generation sulfonylurea compound with hypoglycemic activity. Gliclazide also increases peripheral insulin sensitivity. This agent is metabolized by CYP2C9.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Chemical structure:1-(3-azabicyclo(3.3.0)Oct-3-Yl)-3-(P-tolylsulfonyl)urea
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search